Clinical Trial Update: Carbon-11 Labeled Sarcosine in Prostate Cancer

View source ↗

Summary

A completed clinical trial evaluating carbon-11 labeled sarcosine for imaging prostate cancer has been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Carbon-11 labeled sarcosine (carbon-11 labeled sarcosine)

Snippet

Sponsor: University of Michigan | Conditions: Prostate Cancer | Status: COMPLETED